{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:18:59Z","timestamp":1791206339467,"version":"4.1.0"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The aim of this study was to assess the prevalence of mutations in\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Plasmodium falciparum<\/jats:named-content>\n            dihydrofolate reductase (\n            <jats:italic>Pfdhfr<\/jats:italic>\n            ) and dihydropteroate synthase (\n            <jats:italic>Pfdhps<\/jats:italic>\n            ) genes among pregnant women using sulfadoxine-pyrimethamine (SP) as an intermittent preventive treatment (IPTp). A molecular epidemiological study of\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">P. falciparum<\/jats:named-content>\n            parasite resistance markers to SP was conducted from August 2010 to February 2012 in Mukono district in central Uganda. DNA was extracted from 413\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">P. falciparum<\/jats:named-content>\n            -positive samples. Real-time PCR, followed by melting curve analysis, was used to characterize point mutations in the\n            <jats:italic>Pfdhfr<\/jats:italic>\n            and\n            <jats:italic>Pfdhps<\/jats:italic>\n            genes that are associated with SP resistance. The prevalence of the single-nucleotide mutations in\n            <jats:italic>Pfdhfr<\/jats:italic>\n            at codons 51I, 59R, and 108N and in\n            <jats:italic>Pfdhps<\/jats:italic>\n            at codons 437G and 540E was high (&gt;98%), reaching 100% fixation after one dose of SP, while the prevalence of 581G was 3.3% at baseline, reaching 12.5% after one dose of SP. At baseline, the prevalence of\n            <jats:italic>Pfdhfr<\/jats:italic>\n            and\n            <jats:italic>Pfdhps<\/jats:italic>\n            quintuple mutations was 89%, whereas the sextuple mutations (including 581G) were not prevalent (3.9%), reaching 16.7% after one dose of SP. However, the numbers of infections at follow-up visits were small, and hence there was insufficient statistical power to test whether there was a true rise in the prevalence of this allele. The overall high frequency of\n            <jats:italic>Pfdhfr<\/jats:italic>\n            and\n            <jats:italic>Pfdhps<\/jats:italic>\n            quintuple mutations throughout pregnancy excluded further analyses of possible associations between certain haplotypes and the risk of lower birth weight and anemia. However, women infected with\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">P. falciparum<\/jats:named-content>\n            had 1.3-g\/dl-lower hemoglobin levels (\n            <jats:italic>P<\/jats:italic>\n            = 0.001) and delivered babies with a 400-g-lower birth weight (\n            <jats:italic>P<\/jats:italic>\n            = 0.001) compared to nonparasitemic women. Despite this, 44 women who were\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">P. falciparum<\/jats:named-content>\n            positive at baseline became negative after one or two doses of SP (i.e., 50.5%), implying that SP-IPTp still has some efficacy.\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">P. falciparum<\/jats:named-content>\n            resistance markers to SP are high in this population, whereas\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">P. falciparum<\/jats:named-content>\n            infection was associated with poor birth outcomes.\n          <\/jats:p>","DOI":"10.1128\/aac.00507-15","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T02:44:58Z","timestamp":1435632298000},"page":"5475-5482","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":38,"title":["Prevalence of Plasmodium falciparum Resistance Markers to Sulfadoxine-Pyrimethamine among Pregnant Women Receiving Intermittent Preventive Treatment for Malaria in Uganda"],"prefix":"10.1128","volume":"59","author":[{"given":"Anthony K.","family":"Mbonye","sequence":"first","affiliation":[{"name":"Ministry of Health, Kampala, Uganda, and School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Birungi","sequence":"additional","affiliation":[{"name":"Division of Entomology, Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie K.","family":"Yanow","sequence":"additional","affiliation":[{"name":"Provincial Laboratory for Public Health, Edmonton, Alberta, Canada"},{"name":"School of Public Health, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Shokoples","sequence":"additional","affiliation":[{"name":"Provincial Laboratory for Public Health, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Malamba","sequence":"additional","affiliation":[{"name":"Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Alifrangis","sequence":"additional","affiliation":[{"name":"Centre for Medical Parasitology, Institute of International Health, Immunology, and Microbiology, University of Copenhagen, and Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Magnussen","sequence":"additional","affiliation":[{"name":"Centre for Medical Parasitology, Institute of International Health, Immunology, and Microbiology, University of Copenhagen, and Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"1005","article-title":"An analysis of malaria in pregnancy in Africa","volume":"61","author":"Brabin BJ","year":"1983","unstructured":"Brabin BJ. 1983. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 61:1005\u20131016.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_2_3_2","first-page":"529","article-title":"Malaria infection of the placenta in The Gambia, West Africa, its incidence and relationship to birth weight and placenta weight","volume":"93","author":"McGregor IA","year":"1983","unstructured":"McGregor IA, Wilson ME, Bilewicz WZ. 1983. Malaria infection of the placenta in The Gambia, West Africa, its incidence and relationship to birth weight and placenta weight. Trans R Soc Trop Med Hyg 93:529\u2013534.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"e_1_3_2_4_2","volume-title":"Uganda clinical guidelines","author":"Uganda Ministry of Health","year":"2010","unstructured":"Uganda Ministry of Health. 2010. Uganda clinical guidelines. Uganda Ministry of Health, Kampala, Uganda."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-213"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.216231"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir374"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00856-06"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4269\/ajtmh.2004.71.758","article-title":"Principal role of dihydropteroate synthetase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda","volume":"71","author":"Dorsey G","year":"2004","unstructured":"Dorsey G, Dokomajilar C, Kiggundu M, Staedke SG, Kamya MR, Rosenthal PJ. 2004. Principal role of dihydropteroate synthetase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda. Am J Trop Med Hyg c71:758\u2013763.","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004569"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/656723"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.4.991-996.2000"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.14.3807"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00623-08"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-152"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-338"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.09-0401"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056183"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0901415106"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1909.130133"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073073"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-195"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-147"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-137"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2005.01414.x"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.meegid.2004.04.002","article-title":"Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria","volume":"4","author":"Talisuna AO","year":"2004","unstructured":"Talisuna AO, Nalunkuma-Kazibwe A, Langi P, Mutabingwa TK, Watkins WW, Van Marck E, Egwang TG, D'Alessandro U. 2004. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria. Infect Genet Evol 4:321\u2013327.","journal-title":"Infect Genet Evol"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4269\/ajtmh.2006.75.375","article-title":"Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members","volume":"75","author":"Malamba SS","year":"2006","unstructured":"Malamba SS, Mermin J, Reingold A, Lule JR, Downing R, Ransom R, Kigozi A, Hunt BM, Hubbard A, Rosenthal PJ, Dorsey G. 2006. Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members. Am J Trop Med Hyg 75:375\u2013380.","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_2_28_2","volume-title":"Uganda malaria indicator survey","author":"Uganda Bureau of Statistics","year":"2009","unstructured":"Uganda Bureau of Statistics. 2009. Uganda malaria indicator survey. Uganda Bureau of Statistics, Kampala, Uganda."},{"key":"e_1_3_2_29_2","volume-title":"Uganda demographic and health survey","author":"Uganda Bureau of Statistics","year":"2011","unstructured":"Uganda Bureau of Statistics. 2011. Uganda demographic and health survey. Uganda Bureau of Statistics, Kampala, Uganda."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01858-08"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00634-10"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.10"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2156-10-5"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2008.10.001"},{"key":"e_1_3_2_35_2","volume-title":"Evidence Review Group on Intermittent Preventive Treatment (IPT) of malaria in pregnancy","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. 2013. Evidence Review Group on Intermittent Preventive Treatment (IPT) of malaria in pregnancy. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-134"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2011.02935.x"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-237"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2006.10.008"},{"key":"e_1_3_2_40_2","volume-title":"National quantification for antimalarial medicines and RDTs","author":"Uganda Ministry of Health","year":"2014","unstructured":"Uganda Ministry of Health. 2014. National quantification for antimalarial medicines and RDTs. Uganda Ministry of Health, Kampala, Uganda."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014425"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1086\/587845"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0588-4"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00498-09"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00507-15","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00507-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:54:12Z","timestamp":1645484052000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00507-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1128\/AAC.00507-15"],"URL":"https:\/\/doi.org\/10.1128\/aac.00507-15","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"2015-03-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-06-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-08-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}